Home » Topics » Regulatory » EMA

EMA
RSS

Tagrisso receives positive opinion in Europe for first-line EGFR-mutated NSCLC

April 30, 2018

EMA's CHMP adopts positive opinion for Dzuveo

April 30, 2018

Biktarvy granted positive opinion in Europe

April 30, 2018

EMA validates type II variation for Keytruda with pemetrexed and chemotherapy in NSCLC

April 24, 2018

EMA grants orphan drug designation for ABO-202 gene therapy program in Batten disease

April 23, 2018

EMA committee hands down negative opinion for masitinib in ALS

April 20, 2018

KB-103 receives orphan medicinal product designation in Europe

April 20, 2018

FDA and EMA accept regulatory submissions for dacomitinib

April 5, 2018

EMA validates MAA for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer

April 4, 2018

EMA accepts Dupixent submission in asthma

April 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...